FDA to fast-track Regeneron drug facility in Saratoga County
Article excerpt
Highlighted: the sentence this signal was extracted from
A sign for Regeneron at the former Quad Graphics property in Saratoga Springs. The drug development and manufacturing firm is building a 1 million-square-foot facility on the former Quad Graphics site. The FDA is helping fast-track the approval of the facility in a new pilot program. SARATOGA SPRINGS - Regeneron Pharmaceuticals has been selected to participate in a new federal pilot program to "fast-track" pharmaceutical drug manufacturing facilities in the United States, a move that could accelerate construction of the company's planned $2 billion plant in Saratoga Springs. The Tarrytown-based biotechnology company was chosen by the U.S. Food and Drug Administration for its planned manufacturing campus on the former Quad/Graphics site in Saratoga Springs. The facility is expected to employ 1,000 workers once completed, in addition to about 500 construction jobs during development. Regeneron, which already employs about 4,500 people in the Capital Region - primarily in Rensselaer County and East Greenbush - announced the Saratoga Springs project last year. The more than 1 million-square-foot facility is expected to cost $2 billion, with New York state providing $35 million in tax incentives. Aerial view of the former Quad Graphics property, where Regeneron is building the 1 million-square-foot facility. The FDA's new PreCheck...
Keep reading with a free account
The rest of this article, and every signal for Regeneron, is in your free account.
